Total Anomalous Pulmonary Venous Connection

  • Anna N. Seale
    From the Royal Brompton Hospital (A.N.S., H.U., J.P., M.R., S.Y.H., K.P.M., S.J., L.S., M.L.R., P.E.F.D.) London, United Kingdom; National Heart and Lung Institute (A.N.S., H.U., S.Y.H., K.P.M., P.E.F.D.), Imperial College, London, United Kingdom; Queen Charlotte's and Chelsea Hospital (A.N.S.), London, United Kingdom; Children's Hospital of Pittsburgh (S.A.W.), Pittsburgh, Pa; Queen Silvia Children's Hospital (J.S., H.B.), Gothenburg, Sweden; Lund University Hospital (K.H., S.J.), Lund, Sweden; and...
  • Hideki Uemura
    From the Royal Brompton Hospital (A.N.S., H.U., J.P., M.R., S.Y.H., K.P.M., S.J., L.S., M.L.R., P.E.F.D.) London, United Kingdom; National Heart and Lung Institute (A.N.S., H.U., S.Y.H., K.P.M., P.E.F.D.), Imperial College, London, United Kingdom; Queen Charlotte's and Chelsea Hospital (A.N.S.), London, United Kingdom; Children's Hospital of Pittsburgh (S.A.W.), Pittsburgh, Pa; Queen Silvia Children's Hospital (J.S., H.B.), Gothenburg, Sweden; Lund University Hospital (K.H., S.J.), Lund, Sweden; and...
  • Steven A. Webber
    From the Royal Brompton Hospital (A.N.S., H.U., J.P., M.R., S.Y.H., K.P.M., S.J., L.S., M.L.R., P.E.F.D.) London, United Kingdom; National Heart and Lung Institute (A.N.S., H.U., S.Y.H., K.P.M., P.E.F.D.), Imperial College, London, United Kingdom; Queen Charlotte's and Chelsea Hospital (A.N.S.), London, United Kingdom; Children's Hospital of Pittsburgh (S.A.W.), Pittsburgh, Pa; Queen Silvia Children's Hospital (J.S., H.B.), Gothenburg, Sweden; Lund University Hospital (K.H., S.J.), Lund, Sweden; and...
  • John Partridge
    From the Royal Brompton Hospital (A.N.S., H.U., J.P., M.R., S.Y.H., K.P.M., S.J., L.S., M.L.R., P.E.F.D.) London, United Kingdom; National Heart and Lung Institute (A.N.S., H.U., S.Y.H., K.P.M., P.E.F.D.), Imperial College, London, United Kingdom; Queen Charlotte's and Chelsea Hospital (A.N.S.), London, United Kingdom; Children's Hospital of Pittsburgh (S.A.W.), Pittsburgh, Pa; Queen Silvia Children's Hospital (J.S., H.B.), Gothenburg, Sweden; Lund University Hospital (K.H., S.J.), Lund, Sweden; and...
  • Michael Roughton
    From the Royal Brompton Hospital (A.N.S., H.U., J.P., M.R., S.Y.H., K.P.M., S.J., L.S., M.L.R., P.E.F.D.) London, United Kingdom; National Heart and Lung Institute (A.N.S., H.U., S.Y.H., K.P.M., P.E.F.D.), Imperial College, London, United Kingdom; Queen Charlotte's and Chelsea Hospital (A.N.S.), London, United Kingdom; Children's Hospital of Pittsburgh (S.A.W.), Pittsburgh, Pa; Queen Silvia Children's Hospital (J.S., H.B.), Gothenburg, Sweden; Lund University Hospital (K.H., S.J.), Lund, Sweden; and...
  • Siew Y. Ho
    From the Royal Brompton Hospital (A.N.S., H.U., J.P., M.R., S.Y.H., K.P.M., S.J., L.S., M.L.R., P.E.F.D.) London, United Kingdom; National Heart and Lung Institute (A.N.S., H.U., S.Y.H., K.P.M., P.E.F.D.), Imperial College, London, United Kingdom; Queen Charlotte's and Chelsea Hospital (A.N.S.), London, United Kingdom; Children's Hospital of Pittsburgh (S.A.W.), Pittsburgh, Pa; Queen Silvia Children's Hospital (J.S., H.B.), Gothenburg, Sweden; Lund University Hospital (K.H., S.J.), Lund, Sweden; and...
  • Karen P. McCarthy
    From the Royal Brompton Hospital (A.N.S., H.U., J.P., M.R., S.Y.H., K.P.M., S.J., L.S., M.L.R., P.E.F.D.) London, United Kingdom; National Heart and Lung Institute (A.N.S., H.U., S.Y.H., K.P.M., P.E.F.D.), Imperial College, London, United Kingdom; Queen Charlotte's and Chelsea Hospital (A.N.S.), London, United Kingdom; Children's Hospital of Pittsburgh (S.A.W.), Pittsburgh, Pa; Queen Silvia Children's Hospital (J.S., H.B.), Gothenburg, Sweden; Lund University Hospital (K.H., S.J.), Lund, Sweden; and...
  • Sheila Jones
    From the Royal Brompton Hospital (A.N.S., H.U., J.P., M.R., S.Y.H., K.P.M., S.J., L.S., M.L.R., P.E.F.D.) London, United Kingdom; National Heart and Lung Institute (A.N.S., H.U., S.Y.H., K.P.M., P.E.F.D.), Imperial College, London, United Kingdom; Queen Charlotte's and Chelsea Hospital (A.N.S.), London, United Kingdom; Children's Hospital of Pittsburgh (S.A.W.), Pittsburgh, Pa; Queen Silvia Children's Hospital (J.S., H.B.), Gothenburg, Sweden; Lund University Hospital (K.H., S.J.), Lund, Sweden; and...
  • Lynda Shaughnessy
    From the Royal Brompton Hospital (A.N.S., H.U., J.P., M.R., S.Y.H., K.P.M., S.J., L.S., M.L.R., P.E.F.D.) London, United Kingdom; National Heart and Lung Institute (A.N.S., H.U., S.Y.H., K.P.M., P.E.F.D.), Imperial College, London, United Kingdom; Queen Charlotte's and Chelsea Hospital (A.N.S.), London, United Kingdom; Children's Hospital of Pittsburgh (S.A.W.), Pittsburgh, Pa; Queen Silvia Children's Hospital (J.S., H.B.), Gothenburg, Sweden; Lund University Hospital (K.H., S.J.), Lund, Sweden; and...
  • Jan Sunnegardh
    From the Royal Brompton Hospital (A.N.S., H.U., J.P., M.R., S.Y.H., K.P.M., S.J., L.S., M.L.R., P.E.F.D.) London, United Kingdom; National Heart and Lung Institute (A.N.S., H.U., S.Y.H., K.P.M., P.E.F.D.), Imperial College, London, United Kingdom; Queen Charlotte's and Chelsea Hospital (A.N.S.), London, United Kingdom; Children's Hospital of Pittsburgh (S.A.W.), Pittsburgh, Pa; Queen Silvia Children's Hospital (J.S., H.B.), Gothenburg, Sweden; Lund University Hospital (K.H., S.J.), Lund, Sweden; and...
  • Katarina Hanseus
    From the Royal Brompton Hospital (A.N.S., H.U., J.P., M.R., S.Y.H., K.P.M., S.J., L.S., M.L.R., P.E.F.D.) London, United Kingdom; National Heart and Lung Institute (A.N.S., H.U., S.Y.H., K.P.M., P.E.F.D.), Imperial College, London, United Kingdom; Queen Charlotte's and Chelsea Hospital (A.N.S.), London, United Kingdom; Children's Hospital of Pittsburgh (S.A.W.), Pittsburgh, Pa; Queen Silvia Children's Hospital (J.S., H.B.), Gothenburg, Sweden; Lund University Hospital (K.H., S.J.), Lund, Sweden; and...
  • Hakan Berggren
    From the Royal Brompton Hospital (A.N.S., H.U., J.P., M.R., S.Y.H., K.P.M., S.J., L.S., M.L.R., P.E.F.D.) London, United Kingdom; National Heart and Lung Institute (A.N.S., H.U., S.Y.H., K.P.M., P.E.F.D.), Imperial College, London, United Kingdom; Queen Charlotte's and Chelsea Hospital (A.N.S.), London, United Kingdom; Children's Hospital of Pittsburgh (S.A.W.), Pittsburgh, Pa; Queen Silvia Children's Hospital (J.S., H.B.), Gothenburg, Sweden; Lund University Hospital (K.H., S.J.), Lund, Sweden; and...
  • Sune Johansson
    From the Royal Brompton Hospital (A.N.S., H.U., J.P., M.R., S.Y.H., K.P.M., S.J., L.S., M.L.R., P.E.F.D.) London, United Kingdom; National Heart and Lung Institute (A.N.S., H.U., S.Y.H., K.P.M., P.E.F.D.), Imperial College, London, United Kingdom; Queen Charlotte's and Chelsea Hospital (A.N.S.), London, United Kingdom; Children's Hospital of Pittsburgh (S.A.W.), Pittsburgh, Pa; Queen Silvia Children's Hospital (J.S., H.B.), Gothenburg, Sweden; Lund University Hospital (K.H., S.J.), Lund, Sweden; and...
  • Michael L. Rigby
    From the Royal Brompton Hospital (A.N.S., H.U., J.P., M.R., S.Y.H., K.P.M., S.J., L.S., M.L.R., P.E.F.D.) London, United Kingdom; National Heart and Lung Institute (A.N.S., H.U., S.Y.H., K.P.M., P.E.F.D.), Imperial College, London, United Kingdom; Queen Charlotte's and Chelsea Hospital (A.N.S.), London, United Kingdom; Children's Hospital of Pittsburgh (S.A.W.), Pittsburgh, Pa; Queen Silvia Children's Hospital (J.S., H.B.), Gothenburg, Sweden; Lund University Hospital (K.H., S.J.), Lund, Sweden; and...
  • Barry R. Keeton
    From the Royal Brompton Hospital (A.N.S., H.U., J.P., M.R., S.Y.H., K.P.M., S.J., L.S., M.L.R., P.E.F.D.) London, United Kingdom; National Heart and Lung Institute (A.N.S., H.U., S.Y.H., K.P.M., P.E.F.D.), Imperial College, London, United Kingdom; Queen Charlotte's and Chelsea Hospital (A.N.S.), London, United Kingdom; Children's Hospital of Pittsburgh (S.A.W.), Pittsburgh, Pa; Queen Silvia Children's Hospital (J.S., H.B.), Gothenburg, Sweden; Lund University Hospital (K.H., S.J.), Lund, Sweden; and...
  • Piers E.F. Daubeney
    From the Royal Brompton Hospital (A.N.S., H.U., J.P., M.R., S.Y.H., K.P.M., S.J., L.S., M.L.R., P.E.F.D.) London, United Kingdom; National Heart and Lung Institute (A.N.S., H.U., S.Y.H., K.P.M., P.E.F.D.), Imperial College, London, United Kingdom; Queen Charlotte's and Chelsea Hospital (A.N.S.), London, United Kingdom; Children's Hospital of Pittsburgh (S.A.W.), Pittsburgh, Pa; Queen Silvia Children's Hospital (J.S., H.B.), Gothenburg, Sweden; Lund University Hospital (K.H., S.J.), Lund, Sweden; and...

書誌事項

タイトル別名
  • Morphology and Outcome From an International Population-Based Study

説明

<jats:sec> <jats:title>Background—</jats:title> <jats:p>Late mortality after repair of total anomalous pulmonary venous connection is frequently associated with pulmonary venous obstruction (PVO). We aimed to describe the morphological spectrum of total anomalous pulmonary venous connection and identify risk factors for death and postoperative PVO.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods and Results—</jats:title> <jats:p>We conducted a retrospective, international, collaborative, population-based study involving all 19 pediatric cardiac centers in the United Kingdom, Ireland, and Sweden. All infants with total anomalous pulmonary venous connection born between 1998 and 2004 were identified. Cases with functionally univentricular circulations or atrial isomerism were excluded. All available data and imaging were reviewed. Of 422 live-born cases, 205 (48.6%) had supracardiac, 110 (26.1%) had infracardiac, 67 (15.9%) had cardiac, and 37 (8.8%) had mixed connections. There were 2 cases (0.5%) of common pulmonary vein atresia. Some patients had extremely hypoplastic veins or, rarely, discrete stenosis of the individual veins. Sixty (14.2%) had associated cardiac anomalies. Sixteen died before intervention. Three-year survival for surgically treated patients was 85.2% (95% confidence interval 81.3% to 88.4%). Risk factors for death in multivariable analysis comprised earlier age at surgery, hypoplastic/stenotic pulmonary veins, associated complex cardiac lesions, postoperative pulmonary hypertension, and postoperative PVO. Sixty (14.8%) of the 406 patients undergoing total anomalous pulmonary venous connection repair had postoperative PVO that required reintervention. Three-year survival after initial surgery for patients with postoperative PVO was 58.7% (95% confidence interval 46.2% to 69.2%). Risk factors for postoperative PVO comprised preoperative hypoplastic/stenotic pulmonary veins and absence of a common confluence.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions—</jats:title> <jats:p>Preoperative clinical and morphological features are important risk factors for postoperative PVO and survival.</jats:p> </jats:sec>

収録刊行物

  • Circulation

    Circulation 122 (25), 2718-2726, 2010-12-21

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ